Page 21 of 25

PA20.1-2 | DIC & Vitamin K Deficiency — Part 4

DIC vs Vitamin K Deficiency vs Liver Disease — The Comparison Table

A color-coded medical comparison table contrasts DIC, vitamin K deficiency, and liver disease using platelet count, PT, aPTT, fibrinogen, and D-dimer patterns. — **Top strip:** Disease overview cards labeled DIC (acute), Vitamin K deficiency, and Liver disease with representative icons.. **Main table:** Rows for Platelet count, PT, aPTT, Fibrinogen, and D-dimer comparing the three disorders.. **DIC column:** Platelet count ↓↓ consumed, PT ↑↑, aPTT ↑↑, fibrinogen ↓↓, D-dimer ↑↑.. **Vitamin K deficiency column:** Platelet count normal, PT ↑↑, aPTT ↑ less than PT, fibrinogen normal, D-dimer normal.. **Liver disease column:** Platelet count ↓ hypersplenism, PT ↑↑, aPTT ↑↑, fibrinogen ↓ severe disease, D-dimer ↑ variable.. **Bottom strip:** Diagnostic takeaway boxes highlighting low fibrinogen plus high D-dimer for DIC, normal platelets and fibrinogen for vitamin K deficiency, and low platelets with broad factor loss for liver disease..

The three-way comparison is a favourite examination question and is essential for clinical practice:

Parameter	DIC (acute)	Vitamin K deficiency	Liver disease
Platelet count	↓↓ (consumed)	Normal	↓ (hypersplenism)
PT	↑↑	↑↑	↑↑
aPTT	↑↑	↑ (less than PT)	↑↑
Fibrinogen	↓↓	Normal	↓ (severe disease)
D-dimer	↑↑↑	Normal	Mildly ↑ (reduced clearance)
Factor VIII level	↓ (consumed)	Normal	Normal or ↑ (key distinction — VIII is NOT synthesised by hepatocytes, made by endothelium)
Schistocytes	Present	Absent	Absent
Correction with vitamin K	No	Yes	Partial only

The factor VIII rule: Factor VIII is synthesised primarily by vascular endothelium (not hepatocytes) and is also an acute-phase reactant. In liver disease, factor VIII is normal or elevated. In DIC, factor VIII is consumed and low. This is the single most reliable biochemical distinguisher between DIC and severe liver disease.

Three-column comparison table showing laboratory parameters and clinical features of DIC, vitamin K deficiency, and liver disease coagulopathy. — **Column A:** DIC showing consumption coagulopathy with decreased platelets, prolonged PT/aPTT, decreased fibrinogen, elevated D-dimer, decreased factor VIII. **Column B:** Vitamin K deficiency showing selective factor deficiency with normal platelets, prolonged PT/aPTT, normal fibrinogen/D-dimer/factor VIII. **Column C:** Liver disease showing synthetic dysfunction with decreased platelets, prolonged PT/aPTT, decreased fibrinogen, normal D-dimer/factor VIII.

CLINICAL PEARL

The "correction test" in clinical practice: When a patient with liver disease has a prolonged PT and bleeds, giving vitamin K IV (10 mg over 30 min) is both diagnostic and therapeutic. If PT corrects significantly (by ≥ 30%) within 6-12 hours, there was a nutritional/malabsorption component. If PT does not correct at all, the liver is the primary problem. In DIC complicating liver disease (a challenging clinical scenario), factor VIII level helps: low factor VIII in a cirrhotic points to superimposed DIC, not just hepatic failure.

Acute vs Chronic DIC — Distinguishing Features

A three-panel comparison diagram contrasts acute decompensated DIC with chronic compensated DIC using onset, triggers, bleeding or thrombosis pattern, platelet count, fibrinogen, and D-dimer changes. — **Panel A:** DIC overview showing blood vessel lumen, fibrin strands, microthrombi, platelet consumption, red blood cells, bleeding droplets, coagulation activation, fibrin deposition, and combined bleeding plus thrombosis.. **Panel B:** Acute decompensated DIC showing abrupt onset over hours, sepsis, placental abruption, amniotic fluid embolism, massive trauma, bleeding from multiple sites, markedly decreased platelets, markedly decreased fibrinogen, and elevated D-dimer.. **Panel C:** Chronic compensated DIC showing insidious onset over weeks to months, metastatic carcinoma, giant haemangioma/Kasabach-Merritt syndrome, retained dead foetus, thrombosis including DVT, PE, Trousseau syndrome, mildly decreased or normal platelets, normal or increased fibrinogen, and elevated D-dimer..

Feature	Acute (decompensated) DIC	Chronic (compensated) DIC
Onset	Abrupt (hours)	Insidious (weeks-months)
Trigger examples	Sepsis, abruption, amniotic fluid embolism, massive trauma	Metastatic carcinoma, giant haemangioma (Kasabach-Merritt), retained dead foetus
Dominant clinical picture	Bleeding from multiple sites	Thrombosis (DVT, PE, Trousseau syndrome)
Platelet count	Markedly ↓	Mildly ↓ or normal (compensated marrow)
Fibrinogen	Markedly ↓	Normal or ↑ (acute-phase response compensates)
D-dimer	↑↑↑	↑↑ (often the only persistent abnormality)
PT/aPTT	Both prolonged	Mildly prolonged or at upper limit of normal

Trousseau syndrome — recurrent migratory thrombophlebitis in visceral malignancy — is a classic presentation of chronic compensated DIC driven by tumour-derived TF and mucin. Its recognition should prompt a search for an underlying carcinoma (classically pancreatic or gastric adenocarcinoma).

SELF-CHECK

A 65-year-old man with known metastatic pancreatic carcinoma develops recurrent deep vein thromboses in alternating limbs over 3 months. His platelet count is 145 × 10⁹/L (borderline low), fibrinogen 4.2 g/L (normal), D-dimer 8.5 mg/L (markedly elevated). Which condition best explains this picture?

A. Acute decompensated DIC secondary to sepsis

B. Chronic compensated DIC (Trousseau syndrome)

C. Vitamin K deficiency from malabsorption

D. Primary fibrinolysis from hepatic failure

Reveal Answer

Answer: B. Chronic compensated DIC (Trousseau syndrome)

This is classic chronic compensated DIC (Trousseau syndrome). The clues are: malignancy (known driver of TF), migratory/recurrent thrombosis rather than bleeding, near-normal platelet count and fibrinogen (compensated by marrow and liver), but markedly elevated D-dimer indicating ongoing subclinical fibrin deposition and lysis. In acute decompensated DIC (A), fibrinogen would be critically low and platelets severely reduced with active bleeding. Vitamin K deficiency (C) causes bleeding, not recurrent thrombosis, with a characteristic PT-first pattern.

Management Principles (Pathology Perspective)

Three-panel pathology infographic comparing management principles for DIC and vitamin K deficiency, emphasizing treating the cause first and replacing deficient hemostatic components. — **Panel A:** Overview of hemostasis management logic: bleeding disorder, cause, consumption or deficiency, platelet plug, fibrin mesh, liver-derived clotting factors, replacement therapy.. **Panel B:** DIC management: obstetric trigger, sepsis, acute promyelocytic leukemia, malignancy-associated thrombosis, microvascular fibrin thrombus, consumed platelets, FFP, cryoprecipitate, platelet concentrate, heparin caution, renal support, ventilatory support for ARDS.. **Panel C:** Vitamin K deficiency management: gut malabsorption, liver vitamin K cycle, factors II VII IX X, parenteral vitamin K IV or IM, neonatal IM prophylaxis, warfarin reversal with vitamin K and 4F-PCC, 6-24 hour onset, FFP for severe bleeding..

Year-2 curriculum requires understanding the rationale, not detailed clinical protocols.

DIC:
• Treat the trigger first — deliver the placenta, start antibiotics for sepsis, initiate ATRA for APL. Without removing the trigger, all other measures are temporary.
• Replace consumed factors and platelets: fresh frozen plasma (FFP) supplies all clotting factors; cryoprecipitate supplies fibrinogen + factor VIII; platelet concentrates for thrombocytopenia.
• Role of heparin is controversial — occasionally used in chronic DIC where thrombosis dominates (Trousseau) but contraindicated when bleeding is the main problem.
• Treat the underlying organ failure (renal support, ventilatory support for ARDS).

Vitamin K deficiency:
• Parenteral vitamin K (IV or IM) — oral route unreliable if malabsorption is the cause.
• Neonates: routine IM vitamin K at birth prevents HDN.
• Warfarin reversal: vitamin K 5-10 mg IV ± four-factor prothrombin complex concentrate (4F-PCC) for urgent reversal; reversal with vitamin K takes 6-24 h.
• Fresh frozen plasma in acute severe vitamin K-deficient bleeding (provides immediate active factors while K1 takes effect).